SCHEMBL6983256

SCHEMBL6983256

CC(C)C[C@@H](C(=O)NN)[C@@H](C(=O)OC(C)(C)C)C(/C=C/c1ccccc1)CCO[Si](c1ccccc1)(c1ccccc1)C(C)(C)C

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.34
NPSR1 Q6W5P4 5/20 0.34
POLB P06746 4/20 0.34
RECQL P46063 2/20 0.34
ALDH1A1 P00352 2/20 0.34
PSMB5 P28074 1/20 0.33
MAPK1 P28482 3/20 0.33
KMT2A Q03164 3/20 0.33
ATM Q13315 2/20 0.33
MEN1 O00255 2/20 0.32
REN P00797 2/20 0.32
TDP1 Q9NUW8 1/20 0.32
ADAM17 P78536 1/20 0.32
HDAC3 O15379 1/20 0.31
HDAC4 P56524 1/20 0.31
HDAC1 Q13547 1/20 0.31
HDAC7 Q8WUI4 1/20 0.31
HDAC2 Q92769 1/20 0.31
HDAC10 Q969S8 1/20 0.31
HDAC11 Q96DB2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6981371 0.94 MAPT (0.32) MAPTNPSR1POLBRECQLALDH1A1
SCHEMBL6986700 0.86 PSMB5 (0.36) MAPTNPSR1POLBRECQLALDH1A1
SCHEMBL6942458 0.85 ADAM17 (0.37) MAPTNPSR1POLBRECQLALDH1A1
SCHEMBL6943368 0.85 ADAM17 (0.37) MAPTNPSR1POLBRECQLALDH1A1
SCHEMBL6983187 0.83 NPSR1 (0.33) MAPTNPSR1POLBRECQLALDH1A1
SCHEMBL6985082 0.82 CTSS (0.35) MAPTPSMB5MAPK1KMT2AATM
SCHEMBL6986589 0.82 PSMB5 (0.34) MAPTNPSR1POLBRECQLALDH1A1
SCHEMBL6983531 0.82 REN (0.41) MAPTNPSR1POLBPSMB5MAPK1
SCHEMBL6981635 0.81 MAPT (0.35) MAPTNPSR1POLBRECQLALDH1A1
SCHEMBL6979636 0.81 ADAM17 (0.35) MAPTNPSR1POLBRECQLALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1089964-B1 HYDRAZINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2003-10-29 EP disclosed
US-6239151-B1 TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES, OSTEOARTHRITIS, RESPIRATORY DISEASES, TUMORS, CACHEXIA, CARDIOVASCULAR DISEASES, FEVER, HAEMORRHAGE AND SEPSIS, HYDRAZINE DERIVATIVES, HOFFMANN-LA ROCHE INC. 2001-05-29 US disclosed
EP-1089964-A1 HYDRAZINE DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2001-04-11 EP disclosed
WO-2000000465-A1 HYDRAZINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2000-01-06 WO disclosed